MedTrace Logo

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT01604161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2016

Last updated 2015-07-03

No results posted yet for this study

Summary

This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature with Turner Syndrome where epiphysial discs are not closed.

Conditions

  • Growth Hormone Disorder
  • Growth Hormone Deficiency in Children
  • Genetic Disorder
  • Turner Syndrome

Interventions

DRUG

somatropin

Collection of safety and efficacy data in connection with use of somatropin (Norditropin®) in daily clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604161 on ClinicalTrials.gov